NCT00487812View on ClinicalTrials.gov

Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

September 30, 2008

Conditions
Ischemic Heart DiseaseMyocardial Infarction
Interventions
PROCEDURE

Low-dose dobutamine Tc-99-m-mibi gated SPECT imaging

All patients will be evaluated by ce-MRI during the initial hospital stay (5th - 6th day)

Trial Locations (1)

63000

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT00487812 - Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI | Biotech Hunter | Biotech Hunter